drugset / Trial / NCT03678532

Effects of Sedation on Clinical, Gasometric and Respiratory Muscle Parameters in Critically Ill COPD Patients

NCT03678532

Completed 97 enrolled Assiut University
RandomizedParallel-groupOpen-labelTreatment

Summary

the investigators conducted a randomized controlled trial in respiratory intensive care unit (RICU) of Assiut University Hospital. COPD patients admitted to RICU were included. Exclusion criteria include: Marked renal impairment, Liver cell failure, neurological disorders, age \<18 or \>70 and pregnancy. Patients were randomly allocated to two groups. Midazolam was used for sedation in both groups. Richmond agitation-sedation score (RASS) was used to monitor level of sedation or agitation. Control group received daily interruption of sedation. intervention group managed by no-sedation strategy. Primary outcome measure: changes in PaCO2 Secondary outcome measures include: changes in PH, heart rate, mean arterial blood pressure, respiratory rate, P0.1 and NIF.

Timeline

Start
2016-07-01
Primary completion
2017-11-01
Completion
2017-12-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Midazolam Small molecule Intravenous

Indications

No indication recorded.